(MENAFNEditorial) NEW YORK, Aug. 18, 2017 /PRNewswire/ --Harwood Feffer LLP () is investigating potential claims against the board of directors of Calpine Corporation ("Calpine" or the "Company") (NYSE: ) concerning the proposed acquisition of the Company by Energy Capital Partners ("Energy Capital").
Under the terms of the offer, Energy Capital would acquire Calpine in a transaction valued at approximately $5.6 billion. Pursuant to the deal, Calpine stockholders will receive $15.25 per share owned. At least one Wall Street analyst had set a price target of $20 for Calpine shares.
Our investigation concerns whether the Calpine board of directors is fulfilling its fiduciary duties, maximizing the value of the Company, disclosing all material benefits and costs, and obtaining full and fair consideration for Company stockholders.
If you own Calpine shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:
Benjamin I. Sachs-Michaels, Esq.
Robert I. Harwood, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212) 935-7400
Email:
Website:
Follow us on Twitter:
Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website () for more information about the firm.
Attorney Advertising. The law firm responsible for this advertisement is Harwood Feffer LLP (). Prior results do not guarantee or predict a similar outcome with respect to any future matter.
View original content:
SOURCE Harwood Feffer LLP
MENAFN1808201700701241ID1095746447
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.